# Merck, Moderna Melanoma Vaccine Study Succeeds

https://mins.news/en/video/26246

- Bloomberg Television, 2026-08-19 13:43 UTC
- Health
- Original: https://www.youtube.com/watch?v=yLDKPqPQz_0

> Merck and Moderna reported positive results from a large late-stage trial of their personalized mRNA cancer vaccine, saying it significantly reduced melanoma recurrence. Melanoma is the deadliest form of skin cancer.

## Related coverage

- [Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue](https://mins.news/en/item/28563) — CNN, 2026-08-21
- [Moderna and Merck say melanoma vaccine succeeds in trial](https://mins.news/en/video/27596) — TRT World, 2026-08-20
- [Moderna, Merck say mRNA treatment cuts melanoma recurrence, spread risk](https://mins.news/en/video/27354) — CNA, 2026-08-20
- [Moderna and Merck unveil mRNA cancer vaccine that cuts melanoma spread](https://mins.news/en/item/26640) — Al Jazeera, 2026-08-19
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19